Stocksigma LogoStocksigma Logo

Pharmaids Pharmaceuticals Board to Consider Q2 FY27 Results on 11th Nov'26

Pharmaids Pharmaceuticals Ltd scheduled a Board of Directors meeting on 11th Nov'26 to consider and approve standalone and consolidated unaudited financial

Pharmaids Pharmaceuticals Board to Consider Q2 FY27 Results on 11th Nov'26

Pharmaids Pharmaceuticals Ltd 路 Intimation 路 11 Nov 2026, 5:30 am

Pharmaids Pharmaceuticals Board to Consider Q2 FY27 Results on 11th Nov'26 Pharmaids Pharmaceuticals Ltd scheduled a Board of Directors meeting on 11th Nov'26 to consider and approve standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Per insider trading regulations, the trading window for dealing in company securities has been closed since 1st Oct'26 and will reopen 48 hours after the declaration of financial results.

Original exchange filing (PDF)

More announcements from Pharmaids Pharmaceuticals Ltd

All Pharmaids Pharmaceuticals Ltd announcements